What Propath does

Propath UK Limited is a specialist contract research organization (CRO) focused on molecular pathology and histopathology services for biopharmaceutical research and development. The company operates from a 12,000 sq ft GLP- and GCP-compliant facility in Hereford, UK, with HTA licensing for human tissue handling. Propath is described as one of the largest GLP/GCP compliant contract pathology laboratories in Europe, with over 40 years of operating history and thousands of completed studies.

The company's service portfolio is anchored in spatial biology, with validated capability across multiple complementary platforms: NanoString GeoMx DSP for whole-transcriptome spatial profiling, NanoString CosMx for single-cell subcellular resolution, NanoString nCounter for bulk gene expression, Lunaphore COMET for hyper-plex sequential immunofluorescence, Akoya PhenoCycler/PhenoImager for high-plex phenotyping, and 10x Xenium for targeted spatial transcriptomics. These are supported by GLP/GCP-compliant histopathology services (tissue processing, special stains, IHC), molecular pathology (RNAscope ISH, proximity ligation assays), digital slide scanning, and cross-platform spatial bioinformatics. Propath is an accredited NanoString Core Lab and was among the first CROs globally to offer CosMx commercially.

Propath generates revenue through managed contract research services on a quote-based, project-by-project model, with pricing dependent on assay type, sample volume, panel complexity, turnaround time, and regulatory compliance requirements. Its go-to-market is consultative, enterprise field sales oriented, targeting biopharma study directors and sponsors directly, with secondary reach into biotech firms and academic medical centers. The customer base includes six of the world's top ten pharmaceutical companies, served through long-term relationships built on regulatory quality and domain specialization rather than broad service breadth.

Name

Propath

Legal name

Propath UK Limited

Website

https://propath.co.uk

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1–10 employees

Short description

Propath is a UK-based specialist CRO offering GLP/GCP-compliant molecular pathology, histopathology, and spatial biology services (GeoMx, CosMx, COMET, Xenium) to biopharmaceutical R&D clients globally, including six of the top ten pharma companies.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Spatial Biology Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

Keywords

• Spatial biology services
• Molecular pathology CRO
• Histopathology contract research
• Biopharmaceutical research services
• Spatial transcriptomics CRO

Headquarters

HQ city

Hereford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Contract Research Services (CRO): Propath operates as a specialist CRO providing molecular pathology, spatial biology, and histopathology services on a contract basis for biopharmaceutical R&D. Services range from sample preparation through to data analysis, with pricing based on project scope, complexity, and turnaround requirements. Full managed service from study design to final reporting.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Propath is a specialist Contract Research Organization providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical drug discovery and development. The company operates multiple advanced platforms (NanoString GeoMx, CosMx, nCounter, Lunaphore COMET, Akoya PhenoCycler/PhenoImager, 10x Xenium) from a GLP/GCP compliant facility in Hereford, UK, delivering full managed-service engagements from study design through sample preparation, assay execution, and spatial bioinformatics data analysis for pharmaceutical and biotech sponsors worldwide.

Product overview

Propath is a specialist Contract Research Organization (CRO) providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical R&D. The company operates as a service provider rather than a software product company, offering a integrated portfolio of spatial biology platforms and laboratory services. Core spatial biology platforms include NanoString GeoMx DSP for spatial transcriptomics/proteomics (up to 18,000 RNA targets), NanoString CosMx for single-cell subcellular resolution analysis, Lunaphore COMET for hyper-plex immunofluorescence (up to 40 markers), Akoya PhenoCycler/PhenoImager for high-plex spatial phenotyping, and 10x Xenium for targeted spatial transcriptomics. Molecular pathology services encompass RNAscope ISH, GLP/GCP compliant IHC, and multiplex method development. Histopathology services include GLP/GCP compliant histology, digital slide scanning, and expert pathology reviews. Spatial bioinformatics services provide cross-platform image analysis and data integration. All services are supported by NanoString nCounter for bulk gene expression analysis. Propath is accredited as a NanoString Core Lab, holds GLP/GCP compliance, and HTA licensing, with over 40 years of experience serving biopharma clients globally including six of the world's top ten pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

• NanoString GeoMx Digital Spatial Profiling Service

Quantifiable outcome

• Trusted by six of the world's top ten pharmaceutical companies
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and secondary.

• NanoStringcoreTechnology or Integration · 1 January 2023Propath is an accredited NanoString Core Lab and established partner offering GeoMx DSP, CosMx, and nCounter services. Partnership enables comprehensive spatial multiomics services including whole transcriptome profiling and Cancer Transcriptome Atlas assays. Propath was among the first CROs globally to offer CosMx single-cell spatial analysis commercially.
• VisiopharmsecondaryTechnology or Integration · 1 January 2023Propath worked with Visiopharm and NanoString to develop AI-driven ROI/AOI selection for GeoMx DSP analysis, presented at SITC 2023. Collaboration enables automated detection of tumor subtypes based on hypoxia and immune infiltrate criteria using Oncotopix Discovery for unbiased, reproducible workflow.
• NanoStringsecondaryTechnology or Integration · 1 January 2020Propath partnered with NanoString to launch a grant programme for researchers exploring COVID-19 pathogenesis and host response, enabling analysis of up to 24 RNA samples using NanoString panels with additional COVID-19 targets including the specific COVID-19 Panel Plus product.
• LunaphorecoreTechnology or IntegrationPropath partnered with Lunaphore to offer hyper-plex immunofluorescence staining using the Lunaphore Comet instrument from their UK facility. The partnership enables fully automated sequential immunofluorescence (seqIF) staining and imaging for robust multiplex analysis of up to 40 different spatial markers per tissue slide, with applications across immuno-oncology, neuroscience, and infectious diseases.
• NanoStringcoreTechnology or IntegrationPropath partnered with NanoString to bring the GeoMx Cancer Transcriptome Atlas to Europe, offering turn-key service for spatial profiling of 1,800 genes on clinical or experimental samples. The assay profiles tumor biology, microenvironment, and immune response with spatial resolution from a single tissue section.
• NanoStringsecondaryTechnology or IntegrationPropath launched a grant programme for researchers developing ADC therapeutics using NanoString's nCounter ADC panel, enabling researchers to road-test the new panel measuring six distinct stages of ADC delivery and response in a single gene expression panel.
• NavincisecondaryTechnology or IntegrationPropath offers Automated Proximity Ligation Assays by Navinci, enabling high-throughput, reproducible detection of protein-protein interactions and post-translational modifications in tissue for biopharma applications using automated PLA assays.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Targos: Targos is a German-based specialist clinical biomarker and pathology CRO supporting pharma clinical trials, with comparable GLP/GCP-compliant immunohistochemistry and molecular pathology offerings akin to Propath's regulated services.
• Flagship Biosciences: Flagship Biosciences is a tissue-based CRO providing IHC, image analysis, and pathology services to biopharma, closely overlapping with Propath's histopathology and quantitative image analysis offerings.
• HistoWiz: HistoWiz is a digital pathology and histology CRO serving academic and biopharma clients with IHC, ISH, and slide scanning services, comparable to Propath's histopathology and digital slide scanning capabilities.
• Mosaic Laboratories: Mosaic Laboratories (part of Labcorp) provides GLP-compliant IHC, multiplex immunohistochemistry, and biomarker assay development for biopharma, mirroring Propath's regulated GLP/GCP-compliant IHC and multiplex method development.

Broad incumbents

• Cell Signaling Technology: Cell Signaling Technology is a broader life-science reagents company with an antibody and IHC services portfolio used by biopharma, representing a larger incumbent with overlapping capabilities to Propath's molecular pathology services.
• NeoGenomics: NeoGenomics is a major clinical and biopharma pathology services provider offering IHC, FISH, and molecular testing at scale, a broader incumbent competing with Propath in regulated biomarker work for clinical trials.
• Labcorp Drug Development: Labcorp Drug Development (formerly Covance) is a full-service CRO offering central lab and biomarker/IHC services to biopharma, representing a broad incumbent overlapping with Propath's regulated central pathology and biomarker work.

Others

• ACD Bio / Bio-Techne (RNAscope): Bio-Techne's ACD Bio division manufactures RNAscope ISH probes and runs associated services; Propath offers RNAscope as a GCP service, making ACD both a technology supplier and partial services competitor.
• Indica Labs: Indica Labs provides digital pathology image-analysis software (HALO) widely used for multiplex IHC and spatial biology workflows, an enabling technology provider adjacent to Propath's spatial bioinformatics services.

Emerging players

• Active Motif: Active Motif offers epigenetics and genomic assay services (e.g., ATAC-Seq, ChIP-Seq) for biopharma, an emerging services player in adjacent molecular biology workflows that may be referenced by the same translational research clients as Propath.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Propath